Australia markets closed

Fisher & Paykel Healthcare Corporation Limited (FPH.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
25.80+0.35 (+1.38%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 15.09B
Enterprise value 15.32B
Trailing P/E 63.30
Forward P/E 48.31
PEG ratio (5-yr expected) 4.47
Price/sales (ttm)9.69
Price/book (mrq)9.45
Enterprise value/revenue 8.96
Enterprise value/EBITDA 32.49

Trading information

Stock price history

Beta (5Y monthly) 0.41
52-week change 32.99%
S&P500 52-week change 322.38%
52-week high 325.99
52-week low 318.58
50-day moving average 323.78
200-day moving average 321.83

Share statistics

Avg vol (3-month) 3302.33k
Avg vol (10-day) 3451.94k
Shares outstanding 5582.17M
Implied shares outstanding 6586.61M
Float 8579.86M
% held by insiders 19.41%
% held by institutions 137.66%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.33
Forward annual dividend yield 41.29%
Trailing annual dividend rate 30.41
Trailing annual dividend yield 31.61%
5-year average dividend yield 41.36
Payout ratio 479.61%
Dividend date 3N/A
Ex-dividend date 405 Dec 2023
Last split factor 25:1
Last split date 327 Sept 2004

Financial highlights

Currency in NZD.

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 15.45%
Operating margin (ttm)18.99%

Management effectiveness

Return on assets (ttm)9.98%
Return on equity (ttm)16.20%

Income statement

Revenue (ttm)1.69B
Revenue per share (ttm)2.92
Quarterly revenue growth (yoy)16.40%
Gross profit (ttm)N/A
EBITDA 438.4M
Net income avi to common (ttm)261.7M
Diluted EPS (ttm)0.41
Quarterly earnings growth (yoy)11.90%

Balance sheet

Total cash (mrq)70.5M
Total cash per share (mrq)0.12
Total debt (mrq)323.4M
Total debt/equity (mrq)18.46%
Current ratio (mrq)2.54
Book value per share (mrq)3.01

Cash flow statement

Operating cash flow (ttm)392.8M
Levered free cash flow (ttm)-87.96M